Date: 11th – 12th January 2020
Venue: Ballroom III, IV, Grand Hyatt Macau,
City of Dreams, Estrada do Istmo, Cotai, Macau
Time: 11th January 2020: 11:30-17:00 / 12th January 2020: 08:30-14:00
Message from HKSUO

The Hong Kong Society of Uro-oncology (HKSUO) was founded four years ago as a platform for multi-speciality discussion and collaboration on urological cancers. During this time the society has played an important role locally in advancing understanding of the latests advances in the man-agement and treatment of the disease, and in the promotion of cutting edge applications and treatments.

This year at the HKSUO Fourth Annual Scientific Meeting we continue this thread but at a regional level. We are very pleased to welcome several world class guest speakers from across the globe to share with us their research and experiences. The speakers will be covering advances in the management of urological cancers, with a focus on the continuing evolution and developments in immuno-therapy and other forms of target therapy.

The meeting will also look at the future direction of research in new and explorative combination therapies in new clinical settings, and in particular advances in the use of bio-markers to predict the response of immune-agents. The potential to push for earlier clinical intervention, achieve precision medicine and highly personalised treatments remains an exciting prospect.

Significant advances continue to be made each year, and with each step forward new and exciting opportunities present themselves. Now more than ever, to provide the best we can to patients, we need to stay at the forefront of medicine.

The HKSUO continues to grow as an organisation. Our diverse membership, that includes a diverse range of specialist professionals, including clinical researchers, practicing doctors, nurses, and other medical practitioners, makes us uniquely able to facilitate cross-disciplinary understanding and collaboration.

It is only with your support has the HKSUO been able to achieve its goals, to continue hosting our Scientific Meetings and to look forward to expanding as a regional platform. Thank you again for supporting us, and we look forward to seeing you at our keynote event.

Topic highlight
of the coming meeting
Advances
in diagnosis
and imaging of
prostate cancer
Management
of M0 CRPC
Updates in
mHSPC
Novel therapy
for prostate
cancer
Oligometastasis in
prostate cancer
Advances
in mRCC
management
Systemic therapy
in NMIBC
Targeted therapy
in urothelial
carcinoma
Meet our 2020 speakers
Dr. Laurence Krieger
Northern Cancer Institute, Australia
Prof. David Crawford
University of Colorado, United States
Dr. Enrique Grande
MD Anderson Cancer Center Madrid, Spain
Prof. Przemyslaw W. Twardowski
John Wayne Cancer Institute at Providence Saint John’s Health Center,
United States
Dr. Ravindran Kanesvaran
National Cancer Centre, Singapore
Associate Prof. Shankar Siva
Peter MacCallum Cancer Centre, Australia
Prof. Bernard Escudier
Institut Gustave Roussy, France
Dr. Daniel Y.C. Heng
Tom Baker Cancer Centre, Canada
Dr. Brian Rini
Vanderbilt University Medical Center, United States
Prof. Sumanta K. Pal
City of Hope Comprehensive Cancer Center, United States
Dr. Peter Chiu
Prince of Wales Hospital
The Chinese University of Hong Kong, Hong Kong
Dr. Angus Leung
Private Oncologist, Hong Kong
Associate Prof. Edmund Chiong
National University Cancer Institute Singapore, Singapore
Dr. Gladys Lo
Hong Kong Sanatorium And Hospital, Hong Kong
Dr. Tim Chan
Queen Elizabeth Hospital, Hong Kong